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Objective: To investigate long-term mortality rates and causes of death in individuals diag-
nosed with type 1 diabetes before the age of 15 years during the period 1989-2012 or known
to paediatric diabetes teams in 1989, in Northern Ireland.
Methods: A cohort of 3129 patients from the Northern Ireland Childhood Diabetes Register
was linked to death registrations and underlying causes, coded according to ICD-9 or ICD-10.
Standardized mortality ratios (SMRs) were calculated as the ratio of observed to expected
deaths by sex, attained age, time since diagnosis, calendar period, and cause of death.
Results: Subjects were followed to December 31, 2012 giving 39 764 person-years of
follow-up (median 12.1 years). In total, 59 subjects had died (1.5 per 1000 person-years)
compared with 19.9 deaths expected, an SMR of 296 (95% confidence interval (CI) 229-382).
Women had a significantly higher excess risk of mortality than men with SMRs of 535 (95%
CI 361-764) and 203 (95% CI 136-291), respectively. Over half of the deaths (56%) were
judged to be related or possibly related to diabetes with most of these due to acute (n = 24)
or late (n = 6) complications.
Conclusions: Subjects with type 1 diabetes diagnosed less than 15 years of age had 3 times
the mortality risk of the general population. Over half of the deaths were related to acute or
chronic complications of diabetes.
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1 | INTRODUCTION
Despite advances in treatment and management, an excess mortality in
people diagnosed with type 1 diabetes compared to the general popula-
tion persists. Most excess mortality in young people with type 1 diabe-
tes has been attributed to acute diabetes-related complications, mainly
diabetic ketoacidosis (DKA) and, to a lesser extent, hypoglycaemia.1 As
both of these complications are largely preventable through education
and improved glycaemic control, as well as increased awareness, one
might anticipate a decline in such deaths in recent years.
Other causes of excess mortality that have been reported in
older patients with diabetes include renal disease and cardiovascular
disease (CVD), both late complications of diabetes.1 In addition, a
high number of drug-related deaths among type 1 diabetes subjects
compared to the general population has been reported.2 With previ-
ous reports that the incidence of type 1 diabetes is increasing both in
Europe3 and worldwide,4 it is important that mortality in these indivi-
duals is monitored to determine if current treatments for type 1 dia-
betes are effective in reducing excess deaths.
A number of population-based studies investigating mortality in
patients with type 1 diabetes diagnosed in childhood and adoles-
cence have been published in recent years but most have relatively
short follow-up after diagnosis.5 Larger studies with longer follow-up
permit investigation of trends in mortality rates over time. In this
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study, we aim to investigate mortality in type 1 diabetes diagnosed in
childhood in Northern Ireland.
2 | PATIENTS AND METHODS
A cohort of subjects diagnosed with type 1 diabetes in Northern Ire-
land was extracted from the Northern Ireland Childhood Diabetes
Register. The cohort consists of 2502 incident cases diagnosed with
type 1 diabetes between January 1989 and December 2012 and who
were prospectively added to the register. A further 627 prevalent
cases, diagnosed with type 1 diabetes under the age of 15 years prior
to 1989 that were known to paediatric diabetes teams at the time
the register was established, were also included.
Information on deaths was obtained through linkage to the
National Health Service patient database maintained by the Northern
Ireland Business Services Organisation using Health and Care number
as a unique identifier. Further information about the causes and cir-
cumstances of deaths were obtained from the Registrar General’s
Office, from postmortem reports obtained from the State Patholo-
gist’s Office and from any other available sources (eg, press reports).
Underlying causes of deaths were as coded by staff of the Regis-
trar General’s Office using International Classification of Diseases (ICD)
revisions 9 (1989-2000) and 10 (2001-2012). One clinician, CRB,
reviewed the available information on all deaths and assigned deaths
to one of the following 6 categories: (1) DKA, (2) hypoglycaemia,
(3) other/uncertain acute complication of diabetes, (4) late complica-
tion of diabetes, (5) possibly related to diabetes, and (6) unrelated to
diabetes. Deaths in categories (1) to (4) were regarded as being defi-
nitely due to diabetes. Where sufficient information was available,
deaths with an underlying cause coded as diabetes were reassigned to
another cause mentioned on the death certificate (eg, coronary heart
disease or chronic renal failure). A second clinician experienced in adult
diabetes care, DRM, reviewed all deaths for which there was doubt
about the assignment and approved all cause reassignments.
The Northern Ireland Childhood Diabetes Register (reference
07/NIR02/78) and the mortality follow-up (reference 13/NIR03/52)
were approved by the Office for Research Ethics Committees North-
ern Ireland. Since 2007 consent has been sought for a child to be
included in the register.
3 | STATISTICAL ANALYSES
Prospective and retrospective cases were followed up from their date
of diagnosis or from January 1989, respectively. Subjects were fol-
lowed until the earliest of their date of death, emigration or the end
of the study on December 31, 2012. The person-years at risk
method6 was used to compare the observed number of deaths in the
register cohort with the number of deaths expected were the cohort
to have experienced Northern Ireland mortality rates specific for each
combination of sex, 5-year period, and 5-year age-group, as published
by the Northern Ireland Registrar General’s Office (http://www.nisra.
gov.uk/demography/default.asp.htm). Standardized mortality ratios
(SMRs) were calculated as the ratio of total observed to total
expected deaths and absolute mortality rates per 1000 person-years
were also calculated. The 95% confidence intervals (CIs) for SMRs
and absolute rates were derived from exact 95% CIs for Poisson dis-
tribution counts and ratios of 2 SMRs with 95% CIs were also
calculated.7
Mortality was reported by sex, cohort subgroup (retrospective or
prospective), attained age, time since diagnosis, and calendar period.
Poisson regression likelihood ratio tests were used to investigate if
SMRs differed significantly between subgroups. Cause-specific SMRs
were also calculated.
4 | RESULTS
There were 48 cases (20 prospective and 28 retrospective) that could
not be linked, for 21 of which (5 prospective and 16 retrospective)
no Health and Care number could be found. All were excluded from
the analysis as were 2 patients for whom consent was withheld.
Three deaths occurring at the time of diagnosis were also excluded
from all analyses. In total, 3129 cases of childhood type 1 diabetes
were included in the analysis providing 39 764 person-years of
follow-up (median follow-up, 12.1 years, interquartile range 5.9-
20.1 years). There were slightly more males than females (51%). Of
these patients, 2502 were prospectively added to the register from
1989 onwards while the remaining 627 patients were added retro-
spectively. In total, 246 (8%) subjects were lost to follow-up at the
time of their move to another part of the UK or their emigration to
another country.
5 | ALL CAUSE-MORTALITY
Overall, there were 59 deaths during the study follow-up (1.5 deaths
per 1000 person-years). Results from the person-years at risk analysis
are shown in Table 1. The 59 deaths in the cohort compared to 19.9
deaths expected from the background population rates gave an over-
all SMR of 296 (95% CI 226-382). The SMR in females was signifi-
cantly higher (χ2 = 13.43, df = 1, P < .001) at 534 (95% CI 360-762)
compared to males with an SMR of 202 (95% CI 136-291). The ratio
of these 2 SMRs was 0.38 (95% CI 0.22-0.65). However, there was
no significant difference in absolute mortality between the 2 sexes
(χ2 = 0.03, df = 1, P = .85). Similar excesses in deaths were observed
in the prospective and retrospective cohort subgroups with SMRs of
282 (95% CI 191-403) and 312 (95% CI 209-448), respectively.
Excess mortality did not appear to be associated with attained age,
time since diagnosis, or calendar period. Absolute mortality rates
increased with age and duration of type 1 diabetes.
6 | CAUSE-SPECIFIC MORTALITY
Diabetes was mentioned on 42 of the 59 death certificates (71%).
Over half of the deaths (56%) were judged to be related to diabetes
or possibly related to diabetes. The majority of diabetes-related
deaths were due to acute complications (n = 24 [41%]). DKA was the
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most common acute complication (n = 15) and 8 deaths were due to
hypoglycaemia. Another death was categorized as an uncertain acute
complication because the postmortem report was inconclusive. Only
6 deaths (10%) were related to late complications of diabetes, a
reflection of the relatively young age of the cohort. Three of the
deaths were deemed possibly related to diabetes although the exact
role played by diabetes could not be determined due to uncertainties
about the cause of death. There were 26 (n = 44%) deaths that were
classified as unrelated to diabetes.
Eight of the 30 deaths with diabetes coded as the underlying
cause could be reassigned to another cause mentioned on the death
certificate (4 due as CVD, 2 as accident and violence including sui-
cide, and 2 as chronic renal disease).
Mean age at death was similar across each cause of death, diabe-
tes (22.7 years), accidents and violence (23.3 years), cancer
(25.2 years), drug misuse (25.0 years), and other (23.4 years), except
CVD (36.5 years). Figure 1 shows the observed and expected deaths
by cause of death. There was no significant excess in deaths due to
cancer, accident or violence (including suicide), or CVD.
Alcohol was mentioned in 7 (12%) of the death certificates or
postmortems. Although drug misuse had been reported in 4 (7%) of
the death certificates or postmortems, only 1 death from uninten-
tional poisoning was registered as the underlying cause and could
therefore contribute to the SMR calculation. This resulted in little evi-
dence of an excess of drug-related deaths (SMR = 76, 95% CI 2-424).
7 | DISCUSSION
The primary aim of this follow-up study was to investigate mortality
in subjects diagnosed with type 1 diabetes before the age of 15 years
in Northern Ireland. During an extensive 24 years of follow-up, there
was a 3-fold excess in mortality in patients with type 1 diabetes com-
pared to the general population (SMR 296, 95% CI 229-382). Signifi-
cant excess was observed in both prospective and retrospective
groups and in each time since diagnosis category.
Our recent systematic review of mortality in young people diag-
nosed with type 1 diabetes showed that, while some of the studies
reported similar excess in deaths, other studies in the review showed a
much higher excess of deaths.8 These latter findings were usually associ-
ated with older studies and studies in countries with higher infant mor-
tality rates and lower health expenditures.8 More recently published
studies9–12 have also shown higher excess mortality in young people
with type 1 diabetes compared to our own study, but these studies per-
tained to patients with an earlier calendar period of diagnosis.
Despite finding that females had a significantly higher risk of
mortality than males compared to the general population (SMR = 534
TABLE 1 Results of mortality follow-up in Northern Ireland Childhood Diabetes Register during 1989-2012
Subgroup Person-years of follow-up Observed (expected) deaths
Mortality rate per 1000
person-years SMR (95% CI) P (P for trend)a
Total 39 764 59 (19.9) 1.5 296 (226, 382)
Sex
Males 20 026 29 (14.3) 1.5 202 (136, 291) <.001
Females 19 739 30 (5.6) 1.5 534 (360, 762)
Cohort subgroup
Prospective 26 363 30 (10.6) 1.1 282 (191, 403) .71
Retrospective 13 401 29 (9.3) 2.2 312 (209, 448)
Attained age
0-14 y 14 086 10 (2.3) 0.7 443 (212, 815) .07 (.73)
15-19 y 9325 10 (4.9) 1.1 204 (98, 376)
20-24 y 6907 9 (4.7) 1.3 190 (87, 361)
25-29 y 4585 17 (3.2) 3.7 540 (314, 864)
30-34 y 2755 6 (2.1) 2.2 285 (104, 620)
35+ y 2106 7 (2.8) 3.3 252 (101, 519)
Time since diagnosis
0-4 y 11 719 8 (2.8) 0.7 285 (123, 561) .92 (.95)
5-9 y 9629 12 (3.9) 1.2 306 (158, 535)
10-14 y 7273 11 (4.1) 1.5 266 (133, 476)
15-19 y 5111 12 (3.4) 2.4 351 (181, 612)
20+ y 6032 16 (5.7) 2.7 283 (162, 460)
Calendar period
1989-1993 4016 9 (1.6) 2.2 548 (250, 1040) .10 (.31)
1994-1998 5915 10 (2.6) 1.7 390 (187, 717)
1999-2003 8286 7 (3.8) 0.9 184 (74, 378)
2004-2008 10 949 12 (5.9) 1.1 205 (106, 357)
2009-2012 10 598 21 (6.1) 2.0 347 (215, 530)
Abbreviations: CI, confidence interval; SMR, standardized mortality ratio.
a P-values from Poisson regression likelihood ratio tests to investigate if SMRs differed between subgroups.
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vs 202), absolute mortality rates were similar (1.5 per 1000 person-
years in both sexes). Such higher excesses relative to the lower back-
ground population death rates in females has been observed in other
studies,5,13–15 although the absolute numbers of excess deaths in
each sex were similar. This finding is an indication that the low mor-
tality experienced in females in the background population is not mir-
rored in women with type 1 diabetes, as absolute mortality rates
were similar in the 2 sexes.
We found that the risk of death was significantly higher in both
prospective and retrospective groups compared to the general popula-
tion (SMRs = 282 and 312, respectively). As expected, most deaths
due to late complications of diabetes, including CVD and chronic renal
failure, occurred in the retrospective group. Subjects in this group were
generally older than the prospective cases and had a longer duration
of diabetes with diagnosis occurring prior to 1989. However, 1 patient
in the prospective cohort died from end-stage renal disease after
21 years of diabetes, highlighting that deaths due to chronic complica-
tions of diabetes can occur at younger ages. Given the fact that the
cohort under study had a maximum follow-up of 24 years, and that
only 5% of follow-up occurred beyond the age of 35 years, it is not
surprising that few deaths due to late complications occurred.
Many diabetes-related deaths are now preventable through
achieving optimum glycated haemoglobin (HbA1c) levels. Sandahl
et al9 identified baseline HbA1c as a significant predictor of mortality
with a 38% increase in risk of death for every 1% increase in HbA1c.
With the implementation of intensive education programmes and
insulin regimens in recent years, one might anticipate a decrease in
the rates of both DKA and severe hypoglycaemia. Thus, it is of major
concern that almost a quarter (24%) of deaths were due to potentially
preventable acute complications of type 1 diabetes. A previous audit
of diabetes care provision and glycaemic control in Northern Ire-
land16 found that mean HbA1c was 8.8% (73 mmol/mol) in 2002
with only 20% of children achieving target levels of less than 7.5%
(58 mmol/mol). It would be expected that if intensive diabetes treat-
ment regimens, and the uptake of insulin pumps in conjunction with
education programmes17 were to increase in the United Kingdom in
line with other countries,18 there would be improvements in
HbA1c19,20 and reductions in subsequent diabetes-related complica-
tions21 and mortality.
High proportions of deaths due to acute complications have been
reported in similar studies.2 This study and other similar studies high-
light that the excess deaths in diabetes patients is largely due to pre-
ventable acute complications and there is a need to identify those
patients who are at risk of such complications. The British Diabetes
Association mortality study22 investigated psychosocial and socioeco-
nomic risk factors of acute deaths in type 1 diabetes patients diag-
nosed under the age of 30 years in the United Kingdom. The authors
found that living alone (odds ratio [OR] = 4.4), past drug misuse
(OR = 5.7), and previous psychiatric referral (OR = 4.6) were signifi-
cantly associated with death from acute complications.
There was little evidence of an excess of drug-related deaths
(including insulin but excluding alcohol and tobacco) in this study
but the numbers were too small for any definitive conclusion. Excess
deaths related to drug misuse in type 1 diabetes patients have pre-
viously been reported by Feltbower et al2 with 6 of the 17 drug-
related fatalities they observed being due to insulin overdoses. In
our study, only 1 death from the suicide was due to insulin over-
dose. However, a high proportion (12%) of deaths in Northern Ire-
land was felt to have been related to alcohol in death certificates or
postmortem reports. A study by Webb et al23 investigating the risk
of unnatural deaths in individuals with diabetes (type 1 or type 2)
reported a 3- to 5-fold increase in risk of deaths related to alcohol
and drug misuse. Another study investigating mortality in individuals
with type 1 diabetes found a high proportion (25%) of alcohol and
drug-related deaths in patients diagnosed before 15 years of age at
20 years duration of diabetes.15 In this study, we found that drug or
alcohol use was mentioned in 15% of the death certificates or post-
mortem reports in Northern Ireland. It is difficult to know the exact
role of alcohol and drug misuse in these patients’ deaths. Alcohol
consumption is known to increase the risk of an immediate and pro-
longed hypoglycaemia24 but it may not necessarily be mentioned in
the registered causes of death. This may be particularly pertinent to
Northern Ireland due to the high level of alcohol consumption
among young people.25,26 We speculate that some young patients
living with this long-term condition, unaware of the hazards of alco-
hol excess, may abuse alcohol potentially placing their safety and
well-being at risk. It is important that education and support is pro-
vided for patients to raise awareness of the risk of alcohol con-
sumption and the effect it can have on metabolic control.
A major strength of this study is that it is unlikely that any deaths
would have been missed as might have occurred if only death certifi-
cates mentioning diabetes had been used to ascertain mortality.27
Furthermore, the availability of death certificates and autopsy reports
0
5
10
15
20
25
30
35
40
45
50
55
60
65
D
ia
be
te
s
N
eo
pl
as
m
s
A
cc
id
en
t a
nd
 v
io
le
nc
e
   
   
 S
ui
ci
de
C
V
D
D
ru
g 
m
is
us
e
O
th
er
 c
au
se
s
A
ll 
ca
us
es
N
u
m
b
er
 o
f 
d
ea
th
s
Cause of death
Observed
Expected
230 (84-500)
120 (65-201)
65 (13-190) 321 (88-822)
76 (2-424)
355 (177-635)
296 (225-382)
FIGURE 1 Observed and expected deaths by cause of death for
deaths (with standardized mortality ratio [SMR] and 95% confidence
interval [CI]) occurring in the Northern Ireland Childhood Diabetes
Register, 1989-2012. Deaths by accident and violence include
suicide. Deaths coded with diabetes as the underlying cause were
reclassified to another cause that was mentioned on the death
certificate. ICD-10 (ICD-9) codes: Diabetes, E10-E14 (250);
neoplasms, C00-C97, D00-D48 (140-239); accident and violence
(including suicide), V00-Y98 (E800-E999); suicide, X60-X84 (E950-
E959); cardiovascular disease (CVD), I00-I99 (390-459); drug misuse,
F11-F16, F18-F19, X40-X44, X60-X64, Y10-Y14, X85 (292, 304,
305.2-305.9, E850-E858, E950.0-E950.5, E980.0-E980.5, E962.0);
other causes, all remaining ICD codes
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provided detailed information on the 59 deaths to allow accurate
assignment and categorization of cause of death.
One limitation of this study is that 246 subjects who were lost to
follow-up and this 8% of the cohort were consequently censored at
their date of emigration from Northern Ireland. The absolute mortal-
ity in this cohort may consequently be underestimated as a higher
proportion of subjects who emigrated were in the older retrospective
subgroup, but our person-years approach to analysis takes age into
account so our SMRs should not be affected as much by this source
of bias. Lastly, despite the availability of death certificates and
autopsy reports, it was still not possible to determine whether some
deaths were directly attributed to diabetes due to difficulty in inter-
preting glucose levels postmortem.28
In conclusion, our data show that there is still a significant excess
in mortality in type 1 diabetes patients in Northern Ireland. With a
high proportion of deaths due to DKA or hypoglycaemia, continuing
efforts should be made to raise awareness and educate patients in
order to improve blood glucose control and reduce the risk of death
due to these preventable complications.
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